The European Commission has confirmed that the EU Tobacco Policy Expert Group (TPEG) will formally conclude its mandate, even as work on the next revision of the Tobacco Products Directive (TPD) continues. While the end of a technical advisory body may appear procedural, it raises important questions about how expertise, evidence, and stakeholder input will…
As nicotine pouches continue to attract regulatory attention, discussion has increasingly focused on isolated clinical observations and precautionary warnings, often without sufficient context on real-world use patterns or comparative risk. This imbalance risks obscuring a more important question for public health: how nicotine pouches are actually used, by whom, and how regulation can address legitimate…
Nicotine pouches continue to expand across multiple markets, even as regulatory scrutiny intensifies and public debate grows more polarised. This sustained growth is not accidental, nor is it driven by novelty alone. It reflects a convergence of behavioural, commercial, and policy dynamics that are reshaping how adult nicotine users move away from combustible cigarettes. For…
A GINN Insight responding to recent Medscape coverage Nicotine pouches are increasingly positioned at the centre of a familiar policy tension: how to protect young people from nicotine initiation without undermining harm-reduction pathways for adults who smoke. Recent media coverage, including a Medscape Medical News feature, rightly raises youth-protection concerns but risks misrepresenting the evidence…
Nicotine pouches are no longer a niche or experimental category. Retail and market indicators now show sustained growth across major U.S. convenience channels, reinforcing a reality that regulators globally can no longer ignore: consumer uptake is happening faster than policy alignment. Recent U.S. retail reporting highlights accelerating sales, expanding shelf presence, and increasing manufacturer investment…
As nicotine pouches gain visibility in multiple markets, debate around their public-health role is intensifying. A recent peer-reviewed study published in JAMA Network Open adds important empirical clarity to that discussion, particularly around who is using nicotine pouches, why they are using them, and what this means for smoking-related harm. Rather than focusing on speculative…
Nicotine pouches are increasingly discussed as a distinct category within the broader harm-reduction landscape, raising important questions about how they should be regulated, communicated, and positioned relative to smoking cessation tools. A recent commentary in The Lancet Public Health provides a timely and balanced lens through which to assess these questions, particularly as policy debates…
As nicotine pouches continue to attract regulatory attention, a recurring challenge for policymakers is separating assumptions from evidence. Much of the debate has focused on hypothetical risks, youth narratives, or product novelty, while comparatively less attention has been paid to how adult users actually perceive and use these products in real-world contexts. A recent peer-reviewed…
Following GINN’s recent market‑insights visit to Lebanon, led by our Director Shem Baldeosingh, we continue to learn from frontline experts who see the realities of nicotine use, smoking, and harm reduction every day. This week, Dr Vera Matta (@dr.veramatta), a respected clinician and public health communicator, highlighted an important point while reviewing REBEL White Slim…
As nicotine pouches continue to expand across multiple markets, questions about who uses them, why they are used, and how they fit into tobacco control strategies are becoming increasingly important. A recent peer-reviewed article published by Springer adds to this evidence base by examining patterns of nicotine pouch use and their implications for public health…